Jump to content
Sclero Forums
Sign in to follow this  
CraigR

Treatment of primary Sjogren syndrome: A systematic review

Recommended Posts

Treatment of primary Sjogren syndrome: A systematic review. In primary Sjögren syndrome, evidence from controlled trials suggests benefits for pilocarpine and cevimeline for sicca features and topical cyclosporine for moderate or severe dry eye. Anti–tumor necrosis factor agents have not shown clinical efficacy, and larger controlled trials are needed to establish the efficacy of rituximab. Manuel Ramos-Casals, MD, PhD. JAMA. 2010;304(4):452-460. (Also see: Treatments for Sjogren Syndrome)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

 

 

Craig Roothoff

ISN Assistant News Guide

International Scleroderma Network(ISN)

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

×
×
  • Create New...